Skip to main content
OpenTrials
Completed

NCT Number: NCT01514136

An Investigation of Ostomy Devices

Coloplast A/S has developed a new ostomy device in 8 versions.

The primary objective of this investigation is to assess and compare the degree of leakage when using the 8 different devices.

The secondary objective is to investigate several performance and safety parameters of the various devices.

The aim of the primary and secondary objectives is to acquire more knowledge about the performance of the newly developed device and inspiration for their further development, if needed.

Given that the investigation is exploratory, pass/fail criteria are not relevant. The investigation result will provide knowledge useful for continued decision-making/device development.

The investigation is designed as a non-blinded, controlled, exploratory investigation that includes a total of 30-40 Danish ileostomy users.

Each subject will test a maximum of 4 convex devices in two rounds of each 4 weeks. Each device will be tested for 7 (± 2) days.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Coloplast A/S

Humlebæk, Denmark, 3050

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be at least 18 years old
  • Have signed the declaration of informed consent
  • Have an ileostomy in a concave area
  • Have had an ileostomy for at least three months
  • Have used convex plates (for convex users) or flat plates (for flat plate users) for the last month
  • Be users of 1-piece or 2-piece open ostomy devices
  • Have an ileostomy with a diameter of less than 33 mm

Exclusion criteria

  • Are pregnant or breast-feeding
  • Have a double-loop ileostomy
  • Have known hypersensitivity or allergy to the devices' component ingredients
  • Are receiving/have received radiation treatment and/or chemotherapy within the last 3 months.
  • Are receiving/have received local peristomal or systemic steroid treatment within the last month
  • Suffer from peristomal skin problems that preclude participation in the investigation (assessed by the investigation nurse)

Treatment and study plan

Ostomy appliance: convex 1-piece drainable

Device

8 variations of an ostomy devices are tested

Primary outcomes

  1. Degree of Leakage

    Time frame: One week

    The degree of leakage under the baseplate was measured on a 24-point scale where 0 point was the best possible outcome with no leakage under the baseplate and 24-point was the worst possible outcome with leakage under the whole plate.

    The scale was developed by Coloplast A/S

Sponsors and collaborators

Lead sponsor

Coloplast A/S

Industry

Registry information

Official study title

CP216: An Exploratory Investigation of Convex Ostomy Devices

Important dates

Study start
2011
Primary completion
2011
Study completion
2012
First posted
Jan 20, 2012
Registry last updated
Mar 11, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.